The US Department of Health and Human Services (HHS) issued contract supports the continued supply of ACAM2000 (Smallpox (Vaccinia) Vaccine, Live) into the US Strategic National Stockpile.
The GEO-LM01 vaccine discussed in this paper provides two sources of viral antigens that mimic a natural viral infection promoting predominantly a balanced T cell response, which is critical for protection against Lassa virus infection.
Scientists have genetically manipulated a harmless form of E. coli to create a vaccine that protects against a hypervirulent form of Klebsiella pneumoniae in mice.
Sixteen out of 18 sows and all 15 pigs for meat vaccinated were healthy after two months.
An Indian vaccine manufacturing company has collaborated with a global research and development organization to produce an oral cholera vaccine for India and several other low and middle-income countries.
Access to conjugate vaccines is limited due to centralized production and cold chain distribution requirements. To combat these challenges, researchers developed a modular technology for in vitro bioconjugate vaccine expression in portable, freeze-dried lysates.
A highly effective Ebola vaccine that has been used for the first time during the current Ebola outbreak in the Democratic Republic of Congo (DRC) is in limited supply prompting a discussion of if and how to deploy a second new Ebola vaccine to supplement the limited supplies.
Researchers assessed whether a new component (pH1N1) of an existing influenza vaccine resulted in greater shedding and immunogenicity.
The trial will evaluate the immunogenicity and safety of three consecutive vaccine lots of the freeze-dried formulation of MVA-BN®smallpox vaccine.
Researchers developed a new vaccine against anthrax that can generate an immune response to anthrax toxin as well as its spores rather than just the toxin as existing vaccines do.